Holzer F J, Olinsky A, Phelan P D
Arch Dis Child. 1981 Jun;56(6):455-9. doi: 10.1136/adc.56.6.455.
The importance of bronchial hyper-reactivity and allergy, and treatment with bronchodilators and corticosteroids, in the management of patients with cystic fibrosis is poorly understood. Three tests generally regarded as useful in the diagnosis of asthma were evaluated in 25 children with cystic fibrosis. The constancy of a child's response was assessed by histamine bronchial provocation, exercise challenge, and tests of skin allergy during a 6-month period. Although a positive response to these tests was related to impaired pulmonary function, 44% of children had variable responses to histamine, 56% to exercise, and 24% to skin tests which were unrelated to exacerbations of chest infection or to changes in pulmonary function. These results show the complex nature of airways hyper-reactivity and allergy in cystic fibrosis, and suggest that 'anti-asthma' therapy is not justified solely on the basis of one positive response to these tests.
支气管高反应性和过敏在囊性纤维化患者管理中的重要性,以及使用支气管扩张剂和皮质类固醇进行治疗,目前尚未得到充分理解。对25名囊性纤维化儿童进行了三项通常被认为对哮喘诊断有用的测试。通过组胺支气管激发试验、运动激发试验以及在6个月期间的皮肤过敏试验来评估儿童反应的稳定性。尽管对这些测试的阳性反应与肺功能受损有关,但44%的儿童对组胺的反应可变,56%对运动的反应可变,24%对皮肤试验的反应可变,这些反应与胸部感染加重或肺功能变化无关。这些结果表明了囊性纤维化中气道高反应性和过敏的复杂性,并表明不能仅基于对这些测试的一次阳性反应就证明“抗哮喘”治疗是合理的。